At Novo Nordisk, we are committed to providing patient-centered care. This commitment to patients is at the core of our Triple Bottom Line – creating a sustainable business that is financially viable socially responsible and environmentally sound – and that is the way we operate.
We take all our commitments very seriously, most of all our commitment to people. Our Patient Assistance Programs (PAP) help those who:
Do not have private health insurance or
Do not qualify for private, local, state, or federal prescription reimbursement
These programs provide a lifeline to people who have difficulty obtaining and affording their medications. Each of our therapeutic areas of focus has a program designed to meet the specific needs of those patients. Some programs offer more than product assistance. For more information and to find out if you or someone you care about is eligible for assistance, please click on the program-specfic link below:
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy, and hormone therapy.
Stock info (NYSE quotes delayed by 15 minutes. Currency in USD)